Claudia Stefanutti | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Evolocumab and lipoprotein apheresis combination therapy may have synergic effects to reduce low-density lipoprotein cholesterol levels in heterozygous familial hypercholesterolemia: A case report	JOURNAL OF CLINICAL APHERESIS	2018
Lipoprotein apheresis and pcsk9-inhibitors. Impact on atherogenic lipoproteins and anti-inflammatory mediators in familial hypercholesterolaemia	CURRENT PHARMACEUTICAL DESIGN	2018
Toward an international consensus - integrating lipoprotein apheresis and new lipid-lowering drugs	JOURNAL OF CLINICAL LIPIDOLOGY	2017
Lipoprotein apheresis downregulates IL-1α, IL-6 and TNF-α mRNA expression in severe dyslipidaemia	ATHEROSCLEROSIS SUPPLEMENTS	2017
Monascus purpureus for statin and ezetimibe intolerant heterozygous familial hypercholesterolaemia patients: A clinical study	ATHEROSCLEROSIS SUPPLEMENTS	2017
Long-term efficacy and safety of the microsomal triglyceride transfer protein inhibitor lomitapide in patients with homozygous familial hypercholesterolemia	CIRCULATION	2017
Therapeutic apheresis in pregnancy: three differential indications with positive maternal and fetal outcome	THERAPEUTIC APHERESIS AND DIALYSIS	2016
Individual analysis of patients with HoFH participating in a phase 3 trial with lomitapide: The Italian cohort	NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES	2016
Supplementation with coenzyme Q10 reduces plasma lipoprotein(a) concentrations but not other lipid indices: A systematic review and meta-analysis	PHARMACOLOGICAL RESEARCH	2016
Relationship between Sustained Reductions in Plasma Lipid and Lipoprotein Concentrations with Apheresis and Plasma Levels and mRNA Expression of PTX3 and Plasma Levels of hsCRP in Patients with HyperLp(a)lipoproteinemia	MEDIATORS OF INFLAMMATION	2016
Scientific Information Security in Information Science and Academic Publishing	ARTIFICIAL ORGANS	2016
The 1(st) and the 2(nd) Italian Consensus Conferences on low-density lipoprotein-apheresis. A practical synopsis and update	BLOOD TRANSFUSION	2016
HyperLp(a)lipoproteinaemia: unmet need of diagnosis and treatment?	BLOOD TRANSFUSION	2016
Management of homozygous familial hypercholesterolemia in real-world clinical practice: A report of 7 Italian patients treated in Rome with lomitapide and lipoprotein apheresis	JOURNAL OF CLINICAL LIPIDOLOGY	2016
Lipoprotein apheresis is essential for managing pregnancies in patients with homozygous familial hypercholesterolemia: Seven case series and discussion	ATHEROSCLEROSIS	2016
ODYSSEY ESCAPE: is PCSK9 inhibition the Trojan Horse for the use of lipoprotein apheresis in familial hypercholesterolaemia?	EUROPEAN HEART JOURNAL	2016
EFFICACY OF ALIROCUMAB IN 1,191 PATIENTS WITH A WIDE SPECTRUM OF MUTATIONS IN GENES CAUSATIVE FOR FAMILIAL HYPERCHOLESTEROLEMIA	65th Annual Scientific Session and Expo of the American-College-of-Cardiology (ACC)	2016
Long-term safety, tolerability, and efficacy of evolocumab in patients with heterozygous familial hypercholesterolaemia	EUROPEAN HEART JOURNAL	2016
Lipoprotein apheresis in the management of familial hypercholesterolaemia: historical perspective and recent advances.	Current atherosclerosis reportsCURRENT ATHEROSCLEROSIS REPORTS	2015
Efficacy and Safety of Pitavastatin in Children and Adolescents at High Future Cardiovascular Risk	THE JOURNAL OF PEDIATRICS	2015